Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
about
Progress in adjuvant chemotherapy for breast cancer: an overviewUtility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Derivation of cancer diagnostic and prognostic signatures from gene expression data.External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.Breast cancer prognostic classification in the molecular era: the role of histological grade.A multichannel Markov random field framework for tumor segmentation with an application to classification of gene expression-based breast cancer recurrence risk.Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer.Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.Agreement on indication for systemic therapy between biopsied tissue and surgical excision specimens in breast cancer patientsPrediction of breast cancer survival using clinical and genetic markers by tumor subtypes.Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients.Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based modelsMeta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen.The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer.Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyValidation of the CancerMath prognostic tool for breast cancer in Southeast Asia.PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients.Biomarkers in Breast Cancer - An UpdateA simple decision analytic solution to the comparison of two binary diagnostic tests.Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Validity of the online PREDICT tool in older patients with breast cancer: a population-based study.Prognostic models in male breast cancer.Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.Histological types of breast cancer: how special are they?Therapeutic management of breast cancer in the elderly.Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review.Biomarkers in the diagnosis of primary and recurrent breast cancer.Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast CancerThe prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.Gene expression profiling in breast cancer.Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes.Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?Internet tools to enhance breast cancer care.
P2860
Q26798078-485952E3-4DA5-469C-AFFF-97AB2A8C2747Q27020973-B5460E6A-F67F-4F6B-9A0C-DB3197ED03F7Q30245184-C05AE3AA-FE70-48BC-B9DB-B868C406DA58Q33748879-8360A07E-970A-4D21-BBEA-AD8AE4D697E9Q34075697-DC3C988B-A446-4F87-A8D8-2CBFB5EB95E6Q34173440-8DD48A70-7E94-4760-B06E-7897BC95E921Q34342315-4D260C8A-3167-4148-B942-9D769636D663Q34416758-AF8BDAD7-E36B-4819-95B6-74122A0E5922Q34423470-BF89C960-D4F9-4F3D-845A-7CED3EF3BD76Q34427448-C8520083-2D1A-41E6-8927-BA124D3173FAQ35046907-ADB8EFDF-4085-45E0-9601-0C1AAECB80F3Q35116141-F45612BE-93E3-4910-B935-4267B4998C3AQ35389904-B5D23EA2-67F4-49C6-A31E-8ABC27606E32Q35558070-E87C8C76-3743-4D53-B9DC-EC67CDFD2CC3Q35665399-9E1FF845-7AAC-412B-A950-363698C1025FQ35678667-F53C70BF-7BE1-4C1A-8754-029A85DB2089Q35962498-BBAF9AA6-B4E9-4545-95EF-07D887487DD4Q36009452-13E00C5A-CC3F-46F5-8F3C-5273A67EEBD9Q36151341-BD66E48B-5621-43D4-90E9-D765C3B908E4Q36171326-D9C988A0-F830-4F15-845F-FC99CF3BE012Q36184231-0CA40313-04AF-4A80-B990-97AB93BC5B9AQ36238168-3B1DAE27-EB2C-40BA-82A8-5D78E11BFF54Q36295142-01846BB2-D984-420D-8595-70DC45474417Q36492300-4AC8E1F2-95AB-465E-9A14-EE89C94337C3Q36738790-96431841-A8E6-499F-92B2-45E8C6A64B4FQ36750558-93F39F89-2896-4D07-B89A-96BFB3D94DE7Q37341927-F12064E9-AA72-4E06-887B-0F6A6377E280Q37559006-3E62F50D-44E3-4B93-B82E-039AB78A47D1Q37746023-66E05163-D692-4A79-95AE-1D5A53DE65CDQ37842506-1B219681-7B96-4C52-885B-D7E5E01BAFF3Q38024305-8E8CB643-02E4-42EE-84AD-905A9B3C8EB3Q38048818-45EE4448-DCDE-4207-8DF9-003814835E9BQ38052925-3BF76042-BFD4-4A70-92B0-BD7D23898A37Q38637900-6D00430A-1181-4803-8948-C4CC20262030Q38820550-72D0429B-3F08-494B-81BB-8BB9B5E3D8A4Q39226891-A9F21600-24E3-41FA-AE69-A7C5C645B3DBQ39449343-24C60649-5EC2-4577-A2BA-9BA155467395Q40155925-523A4B45-2CC9-4067-8755-4B052951AF6EQ41611004-DCAF80F0-FA6D-4421-BA63-78CEC2616CE3Q42334186-A11C318E-CB3D-47F7-A7FC-1CD977C2EBD4
P2860
Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Calibration and discriminatory ...... ed retrospective cohort study.
@ast
Calibration and discriminatory ...... ed retrospective cohort study.
@en
type
label
Calibration and discriminatory ...... ed retrospective cohort study.
@ast
Calibration and discriminatory ...... ed retrospective cohort study.
@en
prefLabel
Calibration and discriminatory ...... ed retrospective cohort study.
@ast
Calibration and discriminatory ...... ed retrospective cohort study.
@en
P2093
P1433
P1476
Calibration and discriminatory ...... sed retrospective cohort study
@en
P2093
Anthonie O van de Velde
Emiel J Rutgers
Laura J van't Veer
Otto Visser
Peter M Ravdin
Stella Mook
Sterre M Rutgers
P304
P356
10.1016/S1470-2045(09)70254-2
P577
2009-10-02T00:00:00Z